Key result
Ultrafiltration aids fluid removal in acute heart failure but is best reserved for diuretic-refractory cases.
Why the study?
Does extracorporeal ultrafiltration improve outcomes in patients with acute heart failure and fluid overload not fully responsive to diuretic therapy?
Does extracorporeal ultrafiltration improve outcomes in patients with acute heart failure and fluid overload not fully responsive to diuretic therapy?
This review highlights the controversial findings regarding ultrafiltration in acute heart failure and emphasizes the need for careful patient selection, particularly targeting those with fluid overload unresponsive to diuretics.
Reserve ultrafiltration for diuretic-refractory acute HF; leaves open standardized protocols and selection for definitive trials.
Most patients presenting with acute heart failure (AHF) show signs and symptoms of fluid overload, which are closely associated with short-term and long-term outcomes. Ultrafiltration is an extremely appealing strategy for patients with AHF and concomitant overt fluid overload not fully responsive to diuretic therapy. However, although there are several theoretical beneficial effects associated with ultrafiltration, published reports have shown controversial findings. Differences in selection of the study population and in ultrafiltration indications and protocols, and high variability in the pharmacologic therapy used for the control group could explain some of these conflicting results. Here, we aimed to provide an overview on the current medical evidence supporting the use of ultrafiltration in AHF, with a special focus on the identification of potential candidates who may benefit the most from this therapeutic option.
No takes yet. Share an insight, caveat, or question.
Milazzo et al. (2017) conducted a review in Acute Heart Failure. Extracorporeal ultrafiltration vs. Intravenous loop diuretics was evaluated. Extracorporeal ultrafiltration is an option for fluid removal in acute heart failure, though conflicting trial evidence suggests it should be reserved for patients truly refractory to diuretics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: